MicroRNAs (miRNAs) are emerging rapidly as a novel class of biomarkers of major organ disorders, including kidney diseases. However, current PCR-based detection methods are not amenable to development for high-throughput, cost-effective miRNA biomarker quantification.

中文翻译：

---

液体活检中 microRNA 肾病生物标志物的鉴定和检测。

MicroRNA (miRNA) 作为一类新型的主要器官疾病（包括肾脏疾病）的生物标志物正在迅速崛起。然而，当前基于 PCR 的检测方法不适合开发高通量、经济高效的 miRNA 生物标志物定量。